Lower second-trimester HGS independently predicts GDM risk and hyperglycemia, supporting its use as an inexpensive initial screening tool in primary care, particularly in resource-limited settings.
Zu et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: